Back to search

Article

The role of the atypical chemokine receptor CCRL2 in myelodysplastic syndrome and secondary acute myeloid leukemia

2021-07-30

Abstract excerpt

<h4>ABSTRACT</h4> The identification of new molecular pathways supporting the growth of myelodysplastic syndrome (MDS) stem and progenitor cells is needed to understand clinical variation and develop targeted therapies. Within myeloid malignancies, men have worse outcomes compared to women, suggesting male sex hormone driven effects in malignant hematopoiesis. The androgen receptor promotes the expression of five...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
ad35c752-6d99-565c-8a3e-4188fc09b0c0
DOI
10.1101/2021.07.29.454394
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 9 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The role of the atypical chemokine receptor CCRL2 in myelodysplastic syndrome and secondary acute myeloid leukemiaDOI 10.1101/2021.07.29.454394
Select a neighboring publication to make it the new centre.